Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 3/2007

01-03-2007

Preemptive Total Gastrectomy for Hereditary Gastric Cancer

Authors: Heriberto Medina-Franco, MD, Rafael Barreto-Zuñiga, MD, Miriam N. García-Alvarez, MD

Published in: Journal of Gastrointestinal Surgery | Issue 3/2007

Login to get access

Abstract

Hereditary gastric cancer is a recently described clinical syndrome, associated with truncating mutation of the E-cadherin gene, named CDH1. It is characterized by autosomal dominant transmission, presentation at an early age, and with diffuse type of gastric adenocarcinoma. Clinical management of these patients is challenging and includes intense endoscopic surveillance or prophylactic gastrectomy, which is associated with short- and long-term morbidity. We report four patients submitted to a prophylactic gastrectomy performed in members of three families with hereditary gastric cancer in a tertiary referral center in Mexico City. These are the first Hispanic families with hereditary gastric cancer reported in the literature.
Literature
1.
go back to reference Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402–405.PubMedCrossRef Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402–405.PubMedCrossRef
2.
go back to reference Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020–1027.PubMedCrossRef Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020–1027.PubMedCrossRef
3.
go back to reference Aarnio M, Salovaara R, Aaltonen LA, et al. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 1997;74:551–555.PubMedCrossRef Aarnio M, Salovaara R, Aaltonen LA, et al. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 1997;74:551–555.PubMedCrossRef
4.
go back to reference Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999;36:873–880.PubMed Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999;36:873–880.PubMed
5.
go back to reference Medina-Franco H, Heslin MJ, Cortés-González R. Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study. Ann Surg Oncol 2000;7:515–519.PubMedCrossRef Medina-Franco H, Heslin MJ, Cortés-González R. Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study. Ann Surg Oncol 2000;7:515–519.PubMedCrossRef
6.
go back to reference Shaw D, Blair V, Framp A, et al. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut 2005;54:461–468.PubMedCrossRef Shaw D, Blair V, Framp A, et al. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut 2005;54:461–468.PubMedCrossRef
7.
go back to reference Chun YS, Lindor NM, Smyrk TC, et al. Germline E-cadherin gene mutations: is prophylactic gastrectomy indicated? Cancer 2001;92:181–187.PubMedCrossRef Chun YS, Lindor NM, Smyrk TC, et al. Germline E-cadherin gene mutations: is prophylactic gastrectomy indicated? Cancer 2001;92:181–187.PubMedCrossRef
8.
go back to reference Huntsman DG, Carneiro F, Lewis FR, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Eng J Med 2001;344:1904–1909.CrossRef Huntsman DG, Carneiro F, Lewis FR, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Eng J Med 2001;344:1904–1909.CrossRef
9.
go back to reference Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics 2001. CA Cancer J Clin 2001;51:15–36.PubMedCrossRef Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics 2001. CA Cancer J Clin 2001;51:15–36.PubMedCrossRef
10.
go back to reference La Vecchia C, Negri E, Franceschi S, et al. Family history and the risk of stomach and colorectal cancer. Cancer 1992;70:50–55.PubMedCrossRef La Vecchia C, Negri E, Franceschi S, et al. Family history and the risk of stomach and colorectal cancer. Cancer 1992;70:50–55.PubMedCrossRef
11.
go back to reference Guilford PJ, Hopkins JB, Grady WM, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 1999;14:249–255.PubMedCrossRef Guilford PJ, Hopkins JB, Grady WM, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 1999;14:249–255.PubMedCrossRef
12.
go back to reference Yoon KA, Ku JL, Yang HK, et al. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet 1999;44:177–180.PubMedCrossRef Yoon KA, Ku JL, Yang HK, et al. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet 1999;44:177–180.PubMedCrossRef
13.
go back to reference Suriano G, Yew S, Ferreira P, et al. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 2005;11:5401–5409.PubMedCrossRef Suriano G, Yew S, Ferreira P, et al. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 2005;11:5401–5409.PubMedCrossRef
14.
go back to reference Pharoah PD, Guilford P, Caldas C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001;121:1348–1353.PubMedCrossRef Pharoah PD, Guilford P, Caldas C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001;121:1348–1353.PubMedCrossRef
15.
go back to reference Humar B, Graziano F, Cascinu S, et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002;21:8192–8195.PubMedCrossRef Humar B, Graziano F, Cascinu S, et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002;21:8192–8195.PubMedCrossRef
16.
go back to reference Park WS, Cho YG, Park JY, et al. A single nucleotide polymorphism in the E-cadherin gene promoter −160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 2003;18:501–504.PubMed Park WS, Cho YG, Park JY, et al. A single nucleotide polymorphism in the E-cadherin gene promoter −160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 2003;18:501–504.PubMed
17.
go back to reference Medina-Franco H, Contreras-Saldívar A, Ramos-De la Medina A, et al. Surgery for stage IV gastric cancer. Am J Surg 2004;187:543–546.PubMedCrossRef Medina-Franco H, Contreras-Saldívar A, Ramos-De la Medina A, et al. Surgery for stage IV gastric cancer. Am J Surg 2004;187:543–546.PubMedCrossRef
Metadata
Title
Preemptive Total Gastrectomy for Hereditary Gastric Cancer
Authors
Heriberto Medina-Franco, MD
Rafael Barreto-Zuñiga, MD
Miriam N. García-Alvarez, MD
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 3/2007
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-007-0122-2

Other articles of this Issue 3/2007

Journal of Gastrointestinal Surgery 3/2007 Go to the issue